Preferred Name |
Anidulafungin |
|
Synonyms |
|
|
Definitions |
A cyclic lipopeptide echinocandin derivative with antifungal activity. Anidulafungin inhibits 1,3 beta-D-glucan synthase, an enzyme involved in fungal cell wall synthesis, resulting in cell lysis and death. This agent is active against Candida species and Aspergillus. (NCI04) |
|
ID |
http://purl.obolibrary.org/obo/NCIT_C38716 |
|
Accepted_Therapeutic_Use_For |
Candidemia |
|
ALT_DEFINITION |
A drug that is used to treat infections caused by fungi. It belongs to the family of drugs called antifungals. |
|
CAS_Registry |
166663-25-8 |
|
CHEBI_ID |
CHEBI:55346 |
|
Chemical_Formula |
C58H73N7O17 |
|
code |
C38716 |
|
Contributing_Source |
CTRP FDA |
|
definition |
A cyclic lipopeptide echinocandin derivative with antifungal activity. Anidulafungin inhibits 1,3 beta-D-glucan synthase, an enzyme involved in fungal cell wall synthesis, resulting in cell lysis and death. This agent is active against Candida species and Aspergillus. (NCI04) |
|
Display_Name |
Anidulafungin |
|
FDA_UNII_Code |
9HLM53094I |
|
in_subset |
http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C176424 |
|
label |
Anidulafungin |
|
Legacy Concept Name |
Anidulafungin |
|
NCI_Drug_Dictionary_ID |
328242 |
|
PDQ_Closed_Trial_Search_ID |
328242 |
|
PDQ_Open_Trial_Search_ID |
328242 |
|
Preferred_Name |
Anidulafungin |
|
prefixIRI |
NCIT:C38716 |
|
prefLabel |
Anidulafungin |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C1142738 |
|
subClassOf |